"It’s no secret that hormones significantly impact autoimmune disorders and any disorder related to systemic inflammation. For example, MS is more common in women than men, as are most thyroid disorders such as Graves’ disease, and the progress of these diseases follows the rise and fall of hormones during the monthly cycle. It has also been known for years that pregnant woman with MS get better in the last trimester of their pregnancy. In the third trimester, the hormone estriol (the gentle estrogen) is at high levels.
It appears that a key role of estriol is to inhibit the escape of white blood cells from blood vessels into the central nervous system, where they can then attack myelin. In testing with MS patients, after the first three months of estriol treatment, brain scans showed the number of lesions in a group with relapsing-remitting MS decreased by 82 percent, and the volume of those lesions decreased by 79 percent (both compared with pre-treatment scans). The decrease persisted for the rest of the first treatment period. When the women stopped taking the estriol over the next six months, the number of lesions gradually increased again, all the way back to pre-treatment levels.
In another study, administering estriol until treatment levels reached levels consistent with those in late pregnancy completely ameliorated the disease. And in recent studies, researchers found that testosterone therapy for those who have MS may help improve cognitive function and slow brain atrophy. It’s believed that testosterone helps protect nerve cells from damage caused by the kind of autoimmune attack that occurs in people with MS."
Like & Share (G.Shyam)
It appears that a key role of estriol is to inhibit the escape of white blood cells from blood vessels into the central nervous system, where they can then attack myelin. In testing with MS patients, after the first three months of estriol treatment, brain scans showed the number of lesions in a group with relapsing-remitting MS decreased by 82 percent, and the volume of those lesions decreased by 79 percent (both compared with pre-treatment scans). The decrease persisted for the rest of the first treatment period. When the women stopped taking the estriol over the next six months, the number of lesions gradually increased again, all the way back to pre-treatment levels.
In another study, administering estriol until treatment levels reached levels consistent with those in late pregnancy completely ameliorated the disease. And in recent studies, researchers found that testosterone therapy for those who have MS may help improve cognitive function and slow brain atrophy. It’s believed that testosterone helps protect nerve cells from damage caused by the kind of autoimmune attack that occurs in people with MS."
Like & Share (G.Shyam)
0 comments:
Post a Comment
thanks for feedback, hope from U to share this!